Previous Close | 24.69 |
Open | 24.59 |
Bid | 25.31 x 200 |
Ask | 25.41 x 400 |
Day's Range | 24.59 - 25.55 |
52 Week Range | 17.53 - 59.84 |
Volume | |
Avg. Volume | 857,612 |
Market Cap | 1.94B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
One of the leaders in the global DMD drugs market is expected to outperform
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.